The company reported a consolidated revenue of ₹4,031 crore for the first quarter of fiscal year 2027, reflecting a significant 12.89% annual growth. This financial achievement underscores the robust performance of its domestic portfolio, which continues to outpace the general Indian pharmaceutical
State officials and local supervisors are currently locked in a high-stakes standoff with the facility’s owners to ensure that critical acute care beds are not permanently lost. This situation has left the residents of Moss Beach and the surrounding Coastside area navigating a landscape of medical
Securing an MSCI AAA ESG rating and an EcoVadis Platinum Medal places WuXi Biologics in the top 1% of companies evaluated for environmental and social governance. This landmark achievement underscores the organization's role as a dominant force in the global healthcare market, particularly as it
The move away from carbon offsetting signals a maturation in corporate sustainability where physical decarbonization takes precedence over accounting-based neutrality claims. This evolution reflects a growing understanding that the pharmaceutical industry must confront its environmental impact
The maturation of artificial intelligence in the life sciences is now being judged by its ability to facilitate commercial execution rather than just generating digital designs. The recent acquisition of the American biotechnology firm Genomatica by Copenhagen-based Again signals a tectonic shift
The rapid establishment of the Varroa destructor mite within the honeybee industry serves as a stark reminder of the near-impossible challenge of eradication once a pest bypasses initial border defenses. Australia currently stands at a critical juncture where traditional island isolation is no
